Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Ray Rueb who wrote (20344)	12/27/2004 10:25:28 AM
From: puborectalis	Read Replies (1) \| Respond to of 78579

DRUG STOCKS: "Novartis (NVS) has exhibited strong relative strength in recent weeks, in spite of the pharma industry's woes. The stock is just under its 52-week high of $50.47, something that can't be said for many other large-cap drug stocks. Novartis has several promising drugs in various stages of development including a potential blockbuster blood-pressure drug. Future growth in this industry depends on development of new products, and NVS has a total of 79 drug projects in their pipeline, including 61 that are in Phases II, III or FDA registration. We think these products will fuel NVS' future growth. Last month I increased my 12- to 18-month target price to $69, as revenues and earnings should continue to grow. As the cloud lifts from big pharma, we think Novartis will benefit. NVS is a strong buy below $55." --Eric Dany, The Stock Prospector

To: Ray Rueb who wrote (20344)	12/30/2004 4:14:42 PM
From: - with a K	Read Replies (1) \| Respond to of 78579

the next interesting stocks Iin order of my interest in them) were ADGO, MSHI, CLF... Cleveland-Cliffs Announces Amendment to ISG Pellet Contract Thursday December 30, 3:07 pm ET CLEVELAND, Dec. 30 /PRNewswire-FirstCall/ -- Cleveland-Cliffs Inc (NYSE: CLF) today announced that it has entered into an amendment to its major Pellet Sale and Purchase Agreement with International Steel Group Inc., for pellet deliveries to ISG Cleveland and ISG Indiana Harbor through 2016. The Company stated that it has been working with ISG to amend the pellet contract for several months to mitigate Cliffs' exposure to future steel price volatility. The amendment significantly raises the base price for pellets, to better reflect current market rates, and moderates the steel price sharing provision accordingly. Beginning in 2005 the base pellet price will be equal to the price under the original agreement as if certain ISG hot band steel prices equaled $400 per ton. In addition, the hot band steel price threshold at which Cliffs' pellet price will escalate has been increased to $400 per ton. Cliffs will receive approximately 75% of the benefit of steel pricing above $400 under the amendment as compared to the original agreement. Commenting on the amendment, John S. Brinzo, Chairman and Chief Executive Officer, said, "We are very pleased to have reached this mutually beneficial agreement with ISG. Since entering into the long-term sales agreement with ISG in 2002, the industry's landscape was changed dramatically. This amendment essentially updates the pricing mechanisms to better reflect the current environment. We have successfully decreased our exposure to potential decreases in hot band steel prices and maintained potential upside." Cleveland-Cliffs Inc, headquartered in Cleveland, Ohio, is the largest producer of iron ore pellets in North America and sells the majority of its pellets to integrated steel companies in the United States and Canada. The Company operates six iron ore mines located in Michigan, Minnesota and Eastern Canada.